Carl Zeiss Meditec AG (ETR:AFX - Get Free Report)'s share price dropped 0.4% on Wednesday . The company traded as low as €51.65 ($60.76) and last traded at €52.20 ($61.41). Approximately 169,701 shares changed hands during trading, an increase of 80% from the average daily volume of 94,405 shares. The stock had previously closed at €52.40 ($61.65).
Carl Zeiss Meditec Trading Up 1.0%
The business's 50-day moving average is €58.57 and its two-hundred day moving average is €56.59. The company has a current ratio of 2.13, a quick ratio of 2.47 and a debt-to-equity ratio of 7.41. The stock has a market capitalization of $4.94 billion, a PE ratio of 28.32, a PEG ratio of 2.83 and a beta of 0.98.
About Carl Zeiss Meditec
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Further Reading
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
